Boston Partners Abb Vie Inc. Transaction History

Boston Partners

$80.6 Billion
Q3 2024

A detailed history of Boston Partners transactions in Abb Vie Inc. stock. As of the latest transaction made, Boston Partners holds 4,183,597 shares of ABBV stock, worth $737 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

4,183,597

Previous 4,186,277 0.06%

Holding current value

$737 Million

Previous $718 Million 15.06%

% of portfolio

1.02%

Previous 0.93%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $439,091 - $534,204	-2,680 Reduced 0.06%	4,183,597 $826 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $466 Million - $545 Million	3,012,735 Added 256.72%	4,186,277 $718 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $4.68 Million - $5.33 Million	-29,272 Reduced 2.43%	1,173,542 $214 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $12.9 Million - $14.5 Million	-93,821 Reduced 7.24%	1,202,814 $186 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $6.45 Million - $7.47 Million	-48,271 Reduced 3.59%	1,296,635 $193 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $213 Million - $265 Million	-1,607,247 Reduced 54.44%	1,344,906 $181 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $306 Million - $353 Million	-2,116,654 Reduced 41.76%	2,952,153 $470 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $150 Million - $179 Million	-1,081,267 Reduced 17.58%	5,068,807 $820 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $23.4 Million - $26.8 Million	174,102 Added 2.91%	6,150,074 $827 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $75.6 Million - $96.1 Million	549,279 Added 10.12%	5,975,972 $913 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $1.7 Million - $2.11 Million	-12,866 Reduced 0.24%	5,426,693 $881 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $40.7 Million - $51.6 Million	379,250 Added 7.49%	5,439,559 $737 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $62.7 Million - $71.2 Million	589,506 Added 13.19%	5,060,309 $546 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $123 Million - $137 Million	1,168,684 Added 35.39%	4,470,803 $504 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $43 Million - $47.3 Million	420,355 Added 14.59%	3,302,119 $357 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $221 Million - $298 Million	2,742,063 Added 1962.81%	2,881,764 $309 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $1.9 Million - $2.23 Million	-22,115 Reduced 13.67%	139,701 $12.2 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $3.63 Million - $4.85 Million	-49,446 Reduced 23.41%	161,816 $15.9 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $194,596 - $295,032	3,017 Added 1.45%	211,262 $16.1 Million
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $2.66 Million - $3.33 Million	-36,926 Reduced 15.06%	208,245 $18.4 Million
Q3 2019 Nov 20, 2019	SELL	$62.98 - $75.72 $375,486 - $451,442	-5,962 Reduced 2.37%	245,171 $18.6 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $399,915 - $511,186	6,087 Added 2.48%	251,133 $18.3 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $18.9 Million - $22.2 Million	245,046 New	245,046 $19.7 Million
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $37.2 Million - $43.8 Million	-482,707 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $37.3 Million - $46 Million	479,461 Added 14770.83%	482,707 $44.5 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $288,601 - $320,834	3,246 New	3,246 $307,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account